IP Library Patent Application 11048763
Patent Application
App. No. 11/048,763

Infant formula supplemented with phospholipids

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/048,763
Abstract

An infant formula supplemented with phospholipids. A composition for feeding infants is claimed. The composition includes an infant formula base and a phospholipid supplement. The supplement includes a product of an enzymatic reaction between a crude phospholipid source and phospholipase-D and includes phosphatidylserine or salts thereof as an effective ingredient. Phosphatidylserine from the phospholipid supplement represents between 0.1% and 19.99% (w/w) of a total phospholipid content of the composition. Preferably the phosphatidylserine has a structural fatty acid chain derived from the raw material lecithin. The composition is more similar to human milk with regard to phospholipid composition. Methods of production and articles of manufacture are also disclosed.

Claims (18)

1 . A pharmaceutical or nutritional or food composition for feeding infants, the composition comprising:

(a) an infant formula base, said formula base formulated to provide at least a source of calories and protein; and

(b) a phospholipid supplement comprising a product of an enzymatic reaction between at least one raw material lecithin and phospholipase-D and including phosphatidylserine or salts thereof as an effective ingredient, said phosphatidylserine from said phospholipid supplement comprising between 0.1% and 19.99% (w/w) out of a total phospholipid content of the composition;

wherein said phosphatidylserine has a structural fatty acid chain derived from said at least one raw material lecithin;

wherein the composition is similar to human milk with regard to a phospholipid composition thereof.

2 . The composition of claim 1 , supplied in a form selected from the group consisting of a powder and a fluid which is ready for use.

3 . The composition of claim 1 , wherein a structural fatty acid chain of said phosphatidylserine is a hydrogenated saturated fatty acid chain.

4 . The composition of claim 1 , wherein said infant formula base includes at least one ingredient selected from the group consisting of milk derived ingredients and soy derived ingredients.

5 . The composition of claim 1 , further comprising at least one ingredient selected from the group consisting of lactose, vegetable oils, skimmed milk powder, whey protein concentrate, Sodium, Calcium, Phosphorus, Potassium, Chloride, Iron, Magnesium, Taurine, Vitamins, Glucose syrup, soy protein isolate, Sucrose, Maltodextrine, Methionine, Taurine, Carnitine, and trace elements.

6 . The composition of claim 1 , further comprising at least one ingredient selected from the group consisting of a pharmaceutical excipient and a food excipient.

7 . A fluid composition comprising said powder of claim 2 which includes said infant formula base and an amount of water sufficient for dilution of all ingredients to their desired cocentrations.

8 . The composition of claim 1 , wherein said at least one raw material lecithin is selected from the group consisting of soy bean lecithin, rapeseed lecithin, and egg yolk lecithin

10 . The composition of claim 1 , supplied as an article of manufacture and further comprising packaging material and instructions for use.

11 . A method of producing a composition for feeding infants, the method comprising:

(a) providing at least one raw material lecithin

(b) enzymatically processing said at least one raw material lecithin with phospholipase-D to produce a phosphatidylserine containing product

(c) combining said phosphatidylserine containing product with an infant formula base to produce the composition for feeding infants, said formula base formulated to provide at least a source of calories and protein;

wherein phospatidylserine from said phosphatidylserine containing product comprises between 0.1% and 19.99% (w/w) of a total phospholipid content of the composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2005
From: RUTENBERG, DAVID
To: LIPOGEN LTD.
Reel/Frame 016259/0267 →